Drug for iron deficiency is now approved for pediatric patients

Key Points

• The aim is to evaluate the safety and efficacy of ferric maltol in treating iron deficiency in pediatric patients.
• Approval process for ferric maltol for patients aged 10 years and older.
• Nurses educate patients and families on drug administration and potential side effects.
• Ferric maltol (Accrufer) received approval for pediatric patients ages 10 and older.
• Education for families on administration and adverse effects is crucial.